Sign in

CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company

Damora Therapeutics, Inc.

Sign in to watch
Ticker
DMRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
371957007
Phone
(781) 281-9020
Business address
100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
Former names
Galecto, Inc., Galecto Inc.
Open-market buys, last 90 days
$252,875
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$252,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Jarrett Jennifer +$253K Director, President and CEO 1 filing
Date Insider Transaction Shares Price Value Owned after
2020-11-02 ORBIMED ADVISORS LLC Director Conversion +822,311 822,311
2020-11-02 ORBIMED ADVISORS LLC Director Conversion +191,787 191,787
2020-11-02 ORBIMED ADVISORS LLC Director Purchase +523,833 $15.00 $7.9M 2,579,657
2020-11-02 ORBIMED ADVISORS LLC Director Purchase +209,500 $15.00 $3.1M 1,031,811
2020-11-02 ORBIMED ADVISORS LLC Director Conversion · Series C-2 Preferred Stock −291,999 0
2020-11-02 ORBIMED ADVISORS LLC Director Conversion · Series C-2 Preferred Stock −116,800 0
2020-11-02 ORBIMED ADVISORS LLC Director Conversion · Series C-4 Preferred Stock −272,533 0
2020-11-02 ORBIMED ADVISORS LLC Director Conversion · Series C-4 Preferred Stock −109,013 0
2020-11-02 ORBIMED ADVISORS LLC Director Conversion · Series C-5 Preferred Stock −77,866 0
2020-11-02 ORBIMED ADVISORS LLC Director Conversion · Series C-5 Preferred Stock −31,147 0
2020-11-02 ORBIMED ADVISORS LLC Director Conversion · Series D Preferred Stock −148,395 0
2020-11-02 ORBIMED ADVISORS LLC Director Conversion · Series D Preferred Stock −59,350 0
2020-11-02 ORBIMED ADVISORS LLC Director Conversion · Series D Preferred Stock −73,773 0
2020-11-02 Munshi Amit Director Conversion +4,793 4,793
2020-11-02 Munshi Amit Director Conversion · Series D Preferred Stock −1,844 0
2020-11-02 Schambye Hans T. Chief Executive Officer Conversion +13,931 39,928
2020-11-02 Schambye Hans T. Chief Executive Officer Conversion · Series C-1 Preferred Stock −5,359 0
2020-11-02 Khuong Chau Quang Director Conversion +2,055,824 2,055,824
2020-11-02 Khuong Chau Quang Director Conversion +822,311 822,311
2020-11-02 Khuong Chau Quang Director Conversion +191,787 191,787

Page 10 of 12 · 227 trades